跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
奥凯乐 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Repotrectinib Capsules
Approved
化学药品
Repotrectinib Capsules
Bristol-Myers Squibb Company
🇨🇳 National Medical Products Administration
Approval Date
May 8, 2024
Approval ID
8ZleOu58gQq
Company
Bristol-Myers Squibb Company
Type
化学药品
Approval Details
Approval Id
8ZleOu58gQq
Approval Number
国药准字HJ20240018
Generic Name
瑞普替尼胶囊
Generic Name En
Repotrectinib Capsules
Trade Name
奥凯乐
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
40mg
Reg Date
2024-05-08
Expired Date
2029-05-07
Company Name
Bristol-Myers Squibb Company
Production Company Name
Patheon Inc
Company Detail Path
/organization/bristol-myers-squibb-company
Production Company Detail Path
/organization/patheon-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 8, 2024
Approval ID
8ZleOu58gQq
Type
化学药品
Back to NMPA Approvals